Home / People / Vincent Dirckx
Portrait of Vincent Dirckx

Vincent Dirckx


CMS DeBacker
Chaussée de La Hulpe 178
1170 Brussels
Languages French, English, Dutch

Vincent started his career in New York working for Kelley Drye & Warren and then Baker & McKenzie. He then joined Freshfields Belgian practice and worked mostly in Brussels but also from London. From 2003 to 2009, he was a corporate and finance partner at Lydian.

In 2009, Vincent became a partner at CMS Belgium. In addition to sitting on the Corporate/M&A Management Committee of CMS, Vincent heads CMS Belgium’s M&A department. Vincent’s practice focuses on mergers and acquisitions, private equity and capital markets in connection with both private and public transactions, whether cross-border or domestic, essentially on behalf of large Belgian and non-Belgian corporates.

Vincent is ranked and recommended in Chambers Europe.

more less

"Thanks so much Vincent (...), I couldn’t be happier with the outcome or with the level of service provided by you and your colleagues at CMS."

Lisa Giles-Klein, Burger King

"I value the fact that Vincent specializes not only in M&A, but also in corporate. For an international group like Delhaize it is crucial to be able to rely on the expertise and swift availability of CMS. Vincent and his colleagues understand the dynamics of international business and the Delhaize way of working. This is of vital importance to us."

Philippe Dechamps, (former) General Counsel Delhaize Group

Relevant experience

  • Ahold Delhaize | Advising Ahold Delhaize, the Dutch new parent company of the Belgian Delhaize Group following their recent 10.6 billion merger, in connection with a range of equity transactions both in Belgium and in the US
  • Delhaize Group | Assisting Delhaize Group, Belgium’s largest retail chin, in connection with the 1 billion acquisition of a competitor across eight European jurisdictions
  • Burger King | Advising Burger King on the acquisition (including due diligence, share purchase agreement and merger control analysis and advice with regard to franchise aspects) of Quick Restaurants (Belgium's largest fast food chain) operated in French overseas territories with the help of CMS Luxembourg and CMS France
  • Korys | Assisting Korys in their investment in the equity of a Swedish company – Greenbyte (leading windfarm management system provider). The process involved due diligence exercise and drafting of all requested legal documentation
  • Bakkavor | Assisting in the sale of Bakkavor Limited’s Belgian business (ready meals) to Culinor, a well-known Belgian player in the same sector
  • Delhaize | Assisting Delhaize in the sale of its brand Tom&Co, the specialist store chain for pet food and care, to investment group PetSerCo
  • Deutsche Bahn | Assisting Deutsche Bahn with the restructuring of their Belgian operations
  • Marsh | Assisting Marsh, the worldwide leader in insurance brokerage, in connection with the acquisition of a Belgian market leader in the same sector
  • Johnson & Johnson | Advising the American multinational consumer products company in connection with a range of divestments through asset transactions
  • Assisting large and mid-cap listed companies in connection with both debt and equity public and private issuings of up to EUR 900 million, as well as on a range of corporate governance and market abuse issues
more less


  • Vincent is the author of various publications in French and English in connection with public take-over bids and M&A transactions. He has also spoken at conferences on topics that relate to his practice areas, including directors’ liability. 
more less


  • 1991 - Université Catholique de Louvain, UCL (Law Degree, Magna Cum Laude)
more less
Sep 2018
CMS European M&A Out­look
Wel­come to the sixth edi­tion of the CMS European M&A Out­look, pub­lished in as­so­ci­ation with Mer­ger­mar­ket. The op­tim­ism amongst deal­makers we re­por­ted in au­tumn last year was well-foun­ded: the mar­ket...
Share­hold­er Act­iv­ism: A European Per­spect­ive
In re­cent years, there has been sig­ni­fic­ant growth in share­hold­er act­iv­ism. These “act­iv­ist share­hold­ers” are fund man­agers (typ­ic­ally hedge funds) who usu­ally ac­quire minor­ity in­terests in lis­ted...


Show only
24 March 2021
CMS European M&A Study 2021
The CMS Cor­por­ate/M&A Group is pleased to launch the thir­teenth edi­tion of the European M&A Study
CMS European M&A Study 2021: Europe pivots to be­come more ‘buy­er-friendly’...
Europe has re­turned to a ‘buy­er-friendly’ en­vir­on­ment, sim­il­ar to the US where more ‘buy­er-friendly’ po­s­i­tions are com­mon, after the COV­ID-19 pan­dem­ic cre­ated more risk-averse at­ti­tudes. As a...
CMS Bel­gi­um ad­vised on the sale of the Scaldis Group to Elis
CMS Bel­gi­um ad­vised the share­hold­ers of Scaldis Group on the sale of their group to Elis, the French stock-lis­ted com­pany. Scaldis is a ma­jor European play­er in the "Clean­room" sec­tor (work­wear for sec­tors...
CMS Bel­gi­um ad­vised Ec­cle­sia Group on the ac­quis­i­tion of Kegels & Van An­t­wer­pen
CMS Bel­gi­um ad­vised Ec­cle­sia Group, the Ger­man par­ent com­pany of Con­cor­dia, on the ac­quis­i­tion of An­t­werp based in­sur­ance broker Kegels & Van An­t­wer­pen. Through this ac­quis­i­tion Ec­cle­sia be­comes the fifth...
CMS Bel­gi­um as­sisted Korys and ETF Part­ners with a second €6 mil­lion in­vest­ment...
CMS Bel­gi­um as­sisted Korys, to­geth­er with ETF Part­ners and Urb­antz' share­hold­ers, in con­nec­tion with a second €6 mil­lion in­vest­ment round in Urb­antz, a lead­ing European SaaS com­pany aim­ing to in­crease...
September 2020
CMS European Out­look 2020
We are pleased to provide you with this year’s edi­tion of the “European M&A Out­look”, pub­lished in co-op­er­a­tion with Mer­ger­mar­ket Our sur­vey provides key in­sights in­to how both cor­por­ate and private...
Who dares wins: European M&A Out­look 2020
The COV­ID-19 pan­dem­ic has taken a heavy toll on European deal­mak­ing activ­ity. However, op­por­tun­it­ies re­main for those will­ing to take risks, ac­cord­ing to the eighth edi­tion of the European M&A Out­look...
CMS as­sisted Cely­ad On­co­logy in the struc­tur­ing and im­ple­ment­a­tion of its...
CMS Bel­gi­um, to­geth­er with Har­vest Law, as­sisted Cely­ad On­co­logy, a Bel­gian bi­otech com­pany lis­ted on Euronext Brus­sels/Par­is and on the Nas­daq Glob­al Mar­ket, in the struc­tur­ing and im­ple­ment­a­tion of...
CMS Bel­gi­um as­sists Korys with a EUR 4 mil­lion fund­ing of Am­paci­mon
A team of CMS Bel­gi­um as­sisted Korys, the in­vest­ment vehicle of the Col­ruyt fam­ily,  with the new fin­an­cing round of the Liège-based start-up Am­paci­mon, spe­cial­ized in smart grids. Korys is joined in...
9 June 2020
Im­pact of COV­ID-19 on European M&A activ­ity
The CMS Cor­por­ate/M&A Group teamed up with in­vest­ment bank Cred­it Suisse to ana­lyse the fin­an­cial and leg­al im­plic­a­tions of the COV­ID-19 pan­dem­ic on M&A trans­ac­tions in West­ern Europe.
10 April 2020
Im­pact of the Coronavir­us on the or­gan­iz­a­tion of an­nu­al gen­er­al meet­ings...
Bel­gian au­thor­it­ies, like some of their European coun­ter­parts, have taken ex­treme meas­ures to fight the spread of Cov­id-19, in­clud­ing re­stric­tions on so­cial gath­er­ings. If these strong meas­ures con­tin­ue...
31 March 2020
Im­pact of Coronavir­us on Bel­gian com­pan­ies’ an­nu­al gen­er­al meet­ings
Bel­gian au­thor­it­ies, like some of their European coun­ter­parts, have taken ex­treme meas­ures to fight the spread of Cov­id-19, in­clud­ing re­stric­tions on so­cial gath­er­ings. If these strong meas­ures con­tin­ue...